KR102594322B1 - 옥사티아진-유사 화합물의 제조방법 - Google Patents

옥사티아진-유사 화합물의 제조방법 Download PDF

Info

Publication number
KR102594322B1
KR102594322B1 KR1020177019296A KR20177019296A KR102594322B1 KR 102594322 B1 KR102594322 B1 KR 102594322B1 KR 1020177019296 A KR1020177019296 A KR 1020177019296A KR 20177019296 A KR20177019296 A KR 20177019296A KR 102594322 B1 KR102594322 B1 KR 102594322B1
Authority
KR
South Korea
Prior art keywords
delete delete
compound
taurolidine
compounds
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177019296A
Other languages
English (en)
Korean (ko)
Other versions
KR20170113546A (ko
Inventor
롤프 베. 화이르만
Original Assignee
가이스틀리히 파마 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가이스틀리히 파마 아게 filed Critical 가이스틀리히 파마 아게
Publication of KR20170113546A publication Critical patent/KR20170113546A/ko
Application granted granted Critical
Publication of KR102594322B1 publication Critical patent/KR102594322B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/04—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups
    • C07C303/12—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups by reaction with thionylhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/78—Halides of sulfonic acids
    • C07C309/79—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms
    • C07C309/82—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms of a carbon skeleton substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/18—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by reaction of sulfides with compounds having functional groups with formation of sulfo or halosulfonyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/09—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing etherified hydroxy groups bound to the carbon skeleton
    • C07C309/10—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing etherified hydroxy groups bound to the carbon skeleton with the oxygen atom of at least one of the etherified hydroxy groups further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/12—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing esterified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/27—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/02—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
    • C07D291/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1020177019296A 2014-12-19 2015-12-17 옥사티아진-유사 화합물의 제조방법 Active KR102594322B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462094580P 2014-12-19 2014-12-19
US62/094,580 2014-12-19
PCT/IB2015/059741 WO2016098054A1 (en) 2014-12-19 2015-12-17 Processes for preparing oxathiazin-like compounds

Publications (2)

Publication Number Publication Date
KR20170113546A KR20170113546A (ko) 2017-10-12
KR102594322B1 true KR102594322B1 (ko) 2023-10-26

Family

ID=55077556

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177019296A Active KR102594322B1 (ko) 2014-12-19 2015-12-17 옥사티아진-유사 화합물의 제조방법

Country Status (21)

Country Link
US (2) US10392355B2 (enExample)
EP (2) EP4011871A3 (enExample)
JP (4) JP6746605B2 (enExample)
KR (1) KR102594322B1 (enExample)
CN (3) CN110776479A (enExample)
AU (2) AU2015365348B2 (enExample)
CA (1) CA2971570A1 (enExample)
CY (1) CY1125047T1 (enExample)
DK (1) DK3233813T3 (enExample)
ES (1) ES2907592T3 (enExample)
HR (1) HRP20220313T1 (enExample)
HU (1) HUE058257T2 (enExample)
IL (1) IL252912B (enExample)
LT (1) LT3233813T (enExample)
MX (2) MX392353B (enExample)
PL (1) PL3233813T3 (enExample)
PT (1) PT3233813T (enExample)
RS (1) RS62955B1 (enExample)
SI (1) SI3233813T1 (enExample)
SM (1) SMT202200091T1 (enExample)
WO (1) WO2016098054A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11591302B2 (en) * 2014-12-19 2023-02-28 Geistlich Pharm A Ag Processes for preparing oxathiazin-like compounds
MX392353B (es) * 2014-12-19 2025-03-24 Geistlich Pharma Ag Procedimientos para preparar compuestos de tipo oxatiazina
BR112018070662A2 (pt) * 2016-04-07 2019-02-05 Geistlich Pharma Ag processos para preparar compostos do tipo oxatiazina
EP3586842A4 (en) * 2017-02-27 2021-04-14 Seed Research Institute Co., Ltd. ANTIFUNGAL COMPOSITION
CN109602744A (zh) * 2018-12-13 2019-04-12 中国人民解放军总医院 荜茇酰胺在制备抗菌消炎药物中的应用
US20220323452A1 (en) * 2019-05-22 2022-10-13 Geistlich Pharma Ag Methods and compositions for inhibiting gapdh
CN114096255B (zh) * 2019-05-22 2024-09-10 盖斯特里希医药公司 用于治疗、预防、抑制或减少细胞因子释放的噁噻嗪二氧化物
AU2020279003B2 (en) * 2019-05-22 2025-07-31 Geistlich Pharma Ag Oxathiazin compounds for inhibiting GAPDH
CN111671758A (zh) * 2020-07-06 2020-09-18 长春迈灵生物工程有限公司 牛磺罗定在制备抗hiv病毒药物中的应用
CN111617086A (zh) * 2020-07-06 2020-09-04 长春迈灵生物工程有限公司 牛磺罗定在制备抗hpv病毒药物中的应用
BR112023000308A2 (pt) * 2020-07-06 2023-03-28 Acad Of Military Medical Sciences Uso de taurolidina contra vírus
IL307990A (en) * 2021-04-29 2023-12-01 Geistlich Pharma Ag Antimicrobial and anticancer agents
CN118724762A (zh) * 2024-06-24 2024-10-01 湖南增达生物科技有限公司 一种牛磺酸的制备新工艺

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080039506A1 (en) * 2004-09-21 2008-02-14 Astellas Pharma Inc. Aminoalcohol Derivatives
WO2013190355A1 (en) * 2012-06-18 2013-12-27 Geistlich Pharma Ag Oxathiazine derivatives as antibacterial and anticancer agents

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1160443B (de) * 1961-11-30 1964-01-02 Hoechst Ag Verfahren zur Herstellung von Tetrahydro-oxathiazin-dioxyden
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
DE1234988B (de) 1964-11-28 1967-02-23 Bayer Ag Verfahren zur Herstellung von Copolymerisaten des Trioxans
DK167393B1 (da) 1985-12-30 1993-10-25 Roussel Uclaf 1-sulfonyl-2-oxo-pyrrolidinderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
GB8617482D0 (en) 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
IT1296926B1 (it) 1997-12-05 1999-08-03 Zambon Spa Procedimento per la preparazione di composti ad attivita' antimicotica
US20080275032A1 (en) * 2006-12-29 2008-11-06 Yuefen Zhou Pyridazinone compounds
JP2008222659A (ja) * 2007-03-14 2008-09-25 Asahi Kasei Corp スルホンアミド化合物の製造方法
WO2008149965A1 (ja) 2007-06-07 2008-12-11 Astellas Pharma Inc. ピリドン化合物
US8088824B2 (en) 2007-08-15 2012-01-03 Reata Pharmaceuticals Inc. Forms of CDDO methyl ester
US20120142676A1 (en) * 2010-08-18 2012-06-07 Gaik-Lean Chee Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules
WO2012070066A1 (en) * 2010-11-23 2012-05-31 Biophore India Pharmaceuticals Pvt. Ltd. Process for the preparation of taurolidine and its intermediates thereof
MX392353B (es) * 2014-12-19 2025-03-24 Geistlich Pharma Ag Procedimientos para preparar compuestos de tipo oxatiazina

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080039506A1 (en) * 2004-09-21 2008-02-14 Astellas Pharma Inc. Aminoalcohol Derivatives
WO2013190355A1 (en) * 2012-06-18 2013-12-27 Geistlich Pharma Ag Oxathiazine derivatives as antibacterial and anticancer agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ORGANIC LETTERS, Vol.5, No.22, pp.4175-4177, 2003*

Also Published As

Publication number Publication date
CA2971570A1 (en) 2016-06-23
AU2015365348A1 (en) 2017-07-13
AU2019261702B2 (en) 2021-03-25
JP7030093B2 (ja) 2022-03-04
HUE058257T2 (hu) 2022-07-28
KR20170113546A (ko) 2017-10-12
DK3233813T3 (da) 2022-03-07
PT3233813T (pt) 2022-03-14
CN107257786B (zh) 2019-12-24
EP3233813B1 (en) 2022-02-02
CY1125047T1 (el) 2023-03-24
JP2018502909A (ja) 2018-02-01
MX2017008112A (es) 2018-02-09
CN110776479A (zh) 2020-02-11
JP6746605B2 (ja) 2020-08-26
NZ733723A (en) 2024-03-22
CN119454714A (zh) 2025-02-18
ES2907592T3 (es) 2022-04-25
RS62955B1 (sr) 2022-03-31
MX2019013194A (es) 2020-01-13
MX369462B (es) 2019-11-08
EP4011871A2 (en) 2022-06-15
WO2016098054A1 (en) 2016-06-23
JP2020040964A (ja) 2020-03-19
MX392353B (es) 2025-03-24
SMT202200091T1 (it) 2022-03-21
LT3233813T (lt) 2022-04-11
US20180370932A1 (en) 2018-12-27
JP7449913B2 (ja) 2024-03-14
JP2024028794A (ja) 2024-03-05
BR112017013188A2 (pt) 2018-04-10
JP2022031717A (ja) 2022-02-22
EP3233813A1 (en) 2017-10-25
WO2016098054A9 (en) 2016-12-22
US10392355B2 (en) 2019-08-27
AU2015365348B2 (en) 2019-11-28
CN107257786A (zh) 2017-10-17
HRP20220313T1 (hr) 2022-05-13
EP4011871A3 (en) 2022-08-24
SI3233813T1 (sl) 2022-05-31
US10968190B2 (en) 2021-04-06
AU2019261702A1 (en) 2019-11-28
IL252912B (en) 2020-01-30
IL252912A0 (en) 2017-08-31
PL3233813T3 (pl) 2022-05-30
US20190389819A1 (en) 2019-12-26
JP7688098B2 (ja) 2025-06-03

Similar Documents

Publication Publication Date Title
KR102594322B1 (ko) 옥사티아진-유사 화합물의 제조방법
US9844555B2 (en) Oxathiazine derivatives as antibacterial and anticancer agents
JPS59225150A (ja) 殺生物性芳香族化合物、その合成および医薬としてのその使用
CN104523664B (zh) 姜黄素类抗肿瘤药物及其应用
US20240368097A1 (en) Processes for preparing oxathiazin-like compounds
HK40076913A (en) Processes for preparing oxathiazin-like compounds
HK1240209A1 (en) Processes for preparing oxathiazin-like compounds
HK1240209B (zh) 制备恶噻嗪样化合物的方法
CN109134470B (zh) 一种含硒化合物及其用途
US20250099443A1 (en) Methods for synthesizing aleutianamine and analogs thereof
BR112017013188B1 (pt) Processos para a preparação de compostos semelhantes à oxatiazina
JPS5841843A (ja) フツ素化ジアミノアルケン誘導体

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170712

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201109

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20221116

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230515

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230823

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20231023

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20231024

End annual number: 3

Start annual number: 1

PG1601 Publication of registration